NASH Symposium

Objectives
This symposium aims to provide an update on the current knowledge of NASH and to inform you on the exciting developments in the field. It is expected that in 2021 the first approved drug for NASH will enter the market. Several well known experts in the field will present the most recent developments. Moreover, a collaboration platform (NASH Clinical Network) will be presented. This meeting is also intended to facilitate collaborations between participants and to provide a momentum to network and meet colleagues working in the field of NASH. It is the intention of the organizers to increase awareness of this growing problem and to expand current knowledge.

Audience
Gastroenterologists, Diabetologists, Endocrinologists, Obesity specialists, Hepatologists, Vascular specialists and pharmaceutical industry.

Apply now
Participation is free of charge. Only a limited number of participants will be admitted. Electronic registration sending an email is a prerequisite. Send to: internesecretariaat@franciscus.nl.